BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 21729523)

  • 21. Adenosine deaminase that acts on RNA 1 p150 in alveolar macrophage is involved in LPS-induced lung injury.
    Wu Y; Wang H; Zhang J; Ma X; Meng J; Li Y; Hou Z; Luo X
    Shock; 2009 Apr; 31(4):410-15. PubMed ID: 18520702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Binding of Three Major Human ADAR Isoforms to Coding and Long Non-Coding Transcripts.
    Galipon J; Ishii R; Suzuki Y; Tomita M; Ui-Tei K
    Genes (Basel); 2017 Feb; 8(2):. PubMed ID: 28208661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ADAR1 polymorphisms contribute to increased susceptibility in pediatric acute lymphoblastic leukemia.
    Cai M; Liu X; Luo A; Yang X; Yan Y; Liu S; Wang X; Luo Z; Wu X; Huang K; Yang L; Jiang H; Xu L; Liu X
    Ann Hematol; 2023 Sep; 102(9):2483-2492. PubMed ID: 37217676
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL6R-STAT3-ADAR1 (P150) interplay promotes oncogenicity in multiple myeloma with 1q21 amplification.
    Teoh PJ; Chung TH; Chng PYZ; Toh SHM; Chng WJ
    Haematologica; 2020 May; 105(5):1391-1404. PubMed ID: 31413087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Aicardi-Goutières Syndrome-Causative Point Mutation in
    Inoue M; Nakahama T; Yamasaki R; Shibuya T; Kim JI; Todo H; Xing Y; Kato Y; Morii E; Kawahara Y
    J Immunol; 2021 Dec; 207(12):3016-3027. PubMed ID: 34772697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccinia virus E3L interferon resistance protein inhibits the interferon-induced adenosine deaminase A-to-I editing activity.
    Liu Y; Wolff KC; Jacobs BL; Samuel CE
    Virology; 2001 Oct; 289(2):378-87. PubMed ID: 11689059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of ADAR1-mediated modulation of gene expression.
    Gommans WM; Maas S
    Biochem Biophys Res Commun; 2008 Dec; 377(1):170-5. PubMed ID: 18835380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and expression profiles of ADAR1 gene, responsible for RNA editing, in responses to dsRNA and GCRV challenge in grass carp (Ctenopharyngodon idella).
    Yang C; Su J; Li Q; Zhang R; Rao Y
    Fish Shellfish Immunol; 2012 Oct; 33(4):1042-9. PubMed ID: 22796906
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-alpha stimulation of liver cells enhances hepatitis delta virus RNA editing in early infection.
    Hartwig D; Schoeneich L; Greeve J; Schütte C; Dorn I; Kirchner H; Hennig H
    J Hepatol; 2004 Oct; 41(4):667-72. PubMed ID: 15464249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia.
    Durinck K; Wallaert A; Van de Walle I; Van Loocke W; Volders PJ; Vanhauwaert S; Geerdens E; Benoit Y; Van Roy N; Poppe B; Soulier J; Cools J; Mestdagh P; Vandesompele J; Rondou P; Van Vlierberghe P; Taghon T; Speleman F
    Haematologica; 2014 Dec; 99(12):1808-16. PubMed ID: 25344525
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of malignant ADAR1 splice isoform switching with Rebecsinib.
    Crews LA; Ma W; Ladel L; Pham J; Balaian L; Steel SK; Mondala PK; Diep RH; Wu CN; Mason CN; van der Werf I; Oliver I; Reynoso E; Pineda G; Whisenant TC; Wentworth P; La Clair JJ; Jiang Q; Burkart MD; Jamieson CHM
    Cell Stem Cell; 2023 Mar; 30(3):250-263.e6. PubMed ID: 36803553
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DLL4 regulates NOTCH signaling and growth of T acute lymphoblastic leukemia cells in NOD/SCID mice.
    Minuzzo S; Agnusdei V; Pusceddu I; Pinazza M; Moserle L; Masiero M; Rossi E; Crescenzi M; Hoey T; Ponzoni M; Amadori A; Indraccolo S
    Carcinogenesis; 2015 Jan; 36(1):115-21. PubMed ID: 25355291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Malignant A-to-I RNA editing by ADAR1 drives T cell acute lymphoblastic leukemia relapse via attenuating dsRNA sensing.
    Rivera M; Zhang H; Pham J; Isquith J; Zhou QJ; Balaian L; Sasik R; Enlund S; Mark A; Ma W; Holm F; Fisch KM; Kuo DJ; Jamieson C; Jiang Q
    Cell Rep; 2024 Feb; 43(2):113704. PubMed ID: 38265938
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RNA adenosine deaminase ADAR1 deficiency leads to increased activation of protein kinase PKR and reduced vesicular stomatitis virus growth following interferon treatment.
    Li Z; Wolff KC; Samuel CE
    Virology; 2010 Jan; 396(2):316-22. PubMed ID: 19913273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Over-expression of ADAR1 in mice does not initiate or accelerate cancer formation
    Mendez Ruiz S; Chalk AM; Goradia A; Heraud-Farlow J; Walkley CR
    NAR Cancer; 2023 Jun; 5(2):zcad023. PubMed ID: 37275274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Limited dsRNA editing impedes leukemia stem cells.
    Pan Y; Kang X
    Trends Cancer; 2024 Apr; 10(4):280-282. PubMed ID: 38458943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ADAR-related activation of adenosine-to-inosine RNA editing during regeneration.
    Witman NM; Behm M; Ohman M; Morrison JI
    Stem Cells Dev; 2013 Aug; 22(16):2254-67. PubMed ID: 23534823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The large form of ADAR 1 is responsible for enhanced hepatitis delta virus RNA editing in interferon-alpha-stimulated host cells.
    Hartwig D; Schütte C; Warnecke J; Dorn I; Hennig H; Kirchner H; Schlenke P
    J Viral Hepat; 2006 Mar; 13(3):150-7. PubMed ID: 16475990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ADAR1 is involved in the regulation of reprogramming human fibroblasts to induced pluripotent stem cells.
    Germanguz I; Shtrichman R; Osenberg S; Ziskind A; Novak A; Domev H; Laevsky I; Jacob-Hirsch J; Feiler Y; Rechavi G; Itskovitz-Eldor J
    Stem Cells Dev; 2014 Mar; 23(5):443-56. PubMed ID: 24192045
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Organ-specific microenvironment modifies diverse functional and phenotypic characteristics of leukemia-associated macrophages in mouse T cell acute lymphoblastic leukemia.
    Chen SY; Yang X; Feng WL; Liao JF; Wang LN; Feng L; Lin YM; Ren Q; Zheng GG
    J Immunol; 2015 Mar; 194(6):2919-29. PubMed ID: 25662994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.